Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lipiodol Deposition in Hypervascular Tumors: Endhole vs. Pressure-modulated Delivery

NCT06204159 is registered in ClinicalTrials.gov with Abramson Cancer Center at Penn Medicine as lead sponsor.

NCT NCT06204159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06204159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lipiodol Deposition in Hypervascular Tumors: Endhole vs. Pressure-modulated Delivery
Lead sponsor
Abramson Cancer Center at Penn Medicine
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 1, 2024
Completion date
December 31, 2026
Enrollment
12 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma, neuroendocrine tumors